Myomo (MYO) Shares Outstanding (Weighted Average) (2016 - 2025)
Myomo posted quarterly Shares Outstanding (Weighted Average) of $38.5 million for Q4 2025, up 397.7% year-on-year from $7.7 million in Q4 2024, and down 8.77% on a QoQ basis from $42.2 million in Q3 2025.
Myomo (MYO) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $38.5 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 397.7% year-over-year to $38.5 million; the trailing twelve-month figure through Dec 2025 stood at $38.5 million (up 397.7% YoY), and the FY2025 full-year result was $38.5 million, up 397.7% from the prior year.
- Shares Outstanding (Weighted Average) for Q4 2025 stood at $38.5 million, down from $42.2 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $42.2 million in Q3 2025 and bottomed at $1191.0 in Q1 2021.
- The 5-year median for Shares Outstanding (Weighted Average) is $7.4 million (2022), against an average of $18.4 million.
- The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) sank 99.0%; it then surged 578063.22% in 2022.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $693643.0 in 2021, then dropped by 1.91% to $680363.0 in 2022, then soared by 4235.82% to $29.5 million in 2023, then slumped by 73.8% to $7.7 million in 2024, then jumped by 397.7% to $38.5 million in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $38.5 million (Q4 2025), $42.2 million (Q3 2025), and $41.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | 38.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 38.47 Mn |
| Sep 30, 2025 | 42.17 Mn |
| Jun 30, 2025 | 41.58 Mn |
| Mar 31, 2025 | 41.45 Mn |
| Dec 31, 2024 | 7.73 Mn |
| Sep 30, 2024 | 37.36 Mn |
| Jun 30, 2024 | 37.37 Mn |
| Mar 31, 2024 | 36.75 Mn |
| Dec 31, 2023 | 29.50 Mn |
| Sep 30, 2023 | 1.92 Mn |
| Jun 30, 2023 | 688,250.00 |
| Mar 31, 2023 | 24.20 Mn |
| Dec 31, 2022 | 680,363.00 |
| Sep 30, 2022 | 7.06 Mn |
| Jun 30, 2022 | 6.90 Mn |
| Mar 31, 2022 | 6.89 Mn |
| Dec 31, 2021 | 693,643.00 |
| Sep 30, 2021 | 5.53 Mn |
| Jun 30, 2021 | 118,696.00 |
| Mar 31, 2021 | 1,191.00 |
| Dec 31, 2020 | 2.71 Mn |
| Sep 30, 2020 | 2.90 Mn |
| Jun 30, 2020 | 2.93 Mn |
| Mar 31, 2020 | 118,696.00 |
| Dec 31, 2019 | 181,176.00 |
| Sep 30, 2019 | 547,091.00 |
| Jun 30, 2019 | 534,452.00 |
| Mar 31, 2019 | 498,050.00 |
| Dec 31, 2018 | 169,063.00 |
| Sep 30, 2018 | 12.24 Mn |
| Jun 30, 2018 | 12.16 Mn |
| Mar 31, 2018 | 11.90 Mn |
| Dec 31, 2017 | 209,248.00 |
| Sep 30, 2017 | 3.19 Mn |
| Jun 30, 2017 | 1.72 Mn |
| Mar 31, 2017 | 1.13 Mn |
| Dec 31, 2016 | 8,228.00 |
| Sep 30, 2016 | 1.11 Mn |
| Jun 30, 2016 | 1.02 Mn |